Skip to main content

Amphastar Pharmaceuticals, Inc.

AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001297184

In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of AMPH: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders2563276+23
Shares32.0M27.7K33.3M+1.32M (+4.1%)
Value$1.47B$1.27M$2.06B+$588.4M (+40.0%)

3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to AMPH in Q4 2023
InstitutionSharesValue% of portfolio
Boone Capital Management LLC400,000$24.7M5.77%
Moody Aldrich Partners LLC63,114$3.90M0.70%
Penserra Capital Management LLC48,749$3.02M0.06%
Trexquant Investment LP38,959$2.41M0.05%
Calamos Advisors LLC19,479$1.20M0.01%
Caitlin John, LLC14,442$893.2K0.73%
Wakefield Asset Management LLLP14,128$873.8K0.32%
Natixis13,400$828.8K0.01%
Advisor Resource Council13,162$814.1K0.09%
Seven Eight Capital, LP12,948$800.8K0.09%
Westover Capital Advisors, LLC10,483$648.4K0.21%
Janney Montgomery Scott LLC10,368$641.0K0.00%
AXS Investments LLC8,000$494.8K0.12%
Jefferies Financial Group Inc.7,800$482.4K0.01%
Navellier & Associates Inc7,727$477.9K0.07%
BI Asset Management Fondsmaeglerselskab A/S7,644$473.0K0.01%
Csenge Advisory Group6,672$412.7K0.03%
National Asset Management, Inc.6,628$409.9K0.01%
Corton Capital Inc.5,915$365.8K0.12%
MML Investors Services, LLC5,871$363.0K0.00%
First Hawaiian Bank5,864$362.7K0.01%
Gallacher Capital Management LLC5,750$355.6K0.20%
Pathstone Holdings, LLC5,683$351.4K0.00%
Court Place Advisors, LLC5,500$340.2K0.11%
O'Shaughnessy Asset Management, LLC4,228$261.5K0.00%
XTX Topco Ltd4,025$248.9K0.05%
Mariner, LLC3,865$239.1K0.00%
Hancock Whitney Corp3,855$238.4K0.01%
Leeward Financial Partners, LLC3,507$216.9K0.10%
Mercer Global Advisors Inc3,399$210.0K0.00%
Captrust Financial Advisors3,346$206.9K0.00%
EntryPoint Capital, LLC748$46.3K0.04%
Principal Securities, Inc.548$33.9K0.00%
McGlone Suttner Wealth Management, Inc.453$28.0K0.01%
Point72 Asia (Singapore) Pte. Ltd.447$27.7K0.01%
Vima LLC290$17.9K0.04%
Johnson Financial Group, Inc.259$16.0K0.00%
Spire Wealth Management280$15.4K0.00%
Contravisory Investment Management, Inc.238$14.7K0.00%
GAMMA Investing LLC242$12.9K0.00%
Trivant Custom Portfolio Group, LLC200$12.4K0.01%
Richardson Financial Services Inc.171$10.6K0.01%
Crewe Advisors LLC71$4.39K0.00%
EverSource Wealth Advisors, LLC60$3.71K0.00%
Advisory Services Network, LLC47$2.91K0.00%
Private Wealth Management Group, LLC40$2.47K0.00%
Horizon Investments, LLC4$2470.00%
DiNuzzo Private Wealth, Inc.2$1240.00%

Sold out (25)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Not filed for Q4 2023 yet (3)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMPH in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Virginia Retirement Systems Et Al22,800$1.05M
Advisor Partners II, LLC4,854$223.2K
Steward Financial Group LLC11$0